22 results on '"Jakobsen, Erik"'
Search Results
2. Phase II trial of delta-tocotrienol in neoadjuvant breast cancer with evaluation of treatment response using ctDNA
3. Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial
4. Forecasting lung cancer incidence, mortality, and prevalence to year 2030
5. Prognostic impact of serum levels of EGFR and EGFR ligands in early-stage breast cancer
6. Dysregulated EGFR pathway in serum in early-stage breast cancer patients: A case control study
7. Prediction of fulvestrant efficacy in patients with advanced breast cancer: retrospective-prospective evaluation of the predictive potential of a multigene expression assay
8. Two open-label, single arm, non-randomized phase II studies of irinotecan for the treatment of metastatic breast cancer in patients with increased copy number of the topoisomerase I gene
9. PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial
10. Achieving Thoracic Oncology data collection in Europe: a precursor study in 35 Countries
11. Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study
12. Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2− advanced breast cancer in the randomized MONALEESA-2 trial
13. Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial
14. Transfer between hospitals as a predictor of delay in diagnosis and treatment of patients with Non-Small Cell Lung Cancer – a register based cohort-study
15. The Effect of Different Comorbidities on Survival of Non-small Cells Lung Cancer Patients
16. Feasibility of a Psychosocial Rehabilitation Intervention to Enhance the Involvement of Relatives in Cancer Rehabilitation: Pilot Study for a Randomized Controlled Trial
17. Serum HER-2: sensitivity, specificity, and predictive values for detecting metastatic recurrence in breast cancer patients
18. Plasma HER2 amplification in cell-free DNA during neoadjuvant chemotherapy in breast cancer
19. Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer
20. Value of post-operative reassessment of estrogen receptor α expression following neoadjuvant chemotherapy with or without gefitinib for estrogen receptor negative breast cancer
21. Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial
22. Automatic detection of esophageal pressure events
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.